Breast cancer. The HER2 (also called ErbB-2) receptor belongs to the epidermal growth factor receptor family of receptors characterized by an extracellular ligand binding domain, a transmembrane domain, and an intracellular domain. This evidence concerns the gene ERBB2 and breast carcinoma.